Deferred Income Tax Liabilities, Net of BIO-RAD LABORATORIES, INC. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
BIO-RAD LABORATORIES, INC. quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • BIO-RAD LABORATORIES, INC. Deferred Income Tax Liabilities, Net for the quarter ending 31 Dec 2025 was $1,059,400,000, a 30% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

BIO-RAD LABORATORIES, INC. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,059,400,000 +$241,400,000 +30% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q3 2025 $872,600,000 -$203,458,000 -19% 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $961,000,000 +$82,538,000 +9.4% 30 Jun 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 $840,800,000 -$700,192,000 -45% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $818,000,000 -$657,500,000 -45% 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q3 2024 $1,076,058,000 -$293,498,000 -21% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $878,462,000 -$523,365,000 -37% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $1,540,992,000 -$228,789,000 -13% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $1,475,500,000 -$294,981,000 -17% 31 Dec 2023 10-K 14 Feb 2025 2024 FY
Q3 2023 $1,369,556,000 -$115,050,000 -7.8% 30 Sep 2023 10-Q 27 Oct 2023 2023 Q3
Q2 2023 $1,401,827,000 -$211,701,000 -13% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $1,769,781,000 -$226,108,000 -11% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $1,770,481,000 -$1,294,095,000 -42% 31 Dec 2022 10-K 16 Feb 2024 2023 FY
Q3 2022 $1,484,606,000 -$2,084,726,000 -58% 30 Sep 2022 10-Q 28 Oct 2022 2022 Q3
Q2 2022 $1,613,528,000 -$928,661,000 -37% 30 Jun 2022 10-Q 29 Jul 2022 2022 Q2
Q1 2022 $1,995,889,000 -$310,223,000 -13% 31 Mar 2022 10-Q 29 Apr 2022 2022 Q1
Q4 2021 $3,064,576,000 +$987,791,000 +48% 31 Dec 2021 10-K 17 Feb 2023 2022 FY
Q3 2021 $3,569,332,000 +$1,726,673,000 +94% 30 Sep 2021 10-Q 29 Oct 2021 2021 Q3
Q2 2021 $2,542,189,000 +$1,085,536,000 +75% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $2,306,112,000 +$1,145,000,000 +99% 31 Mar 2021 10-Q 30 Apr 2021 2021 Q1
Q4 2020 $2,076,785,000 +$1,078,998,000 +108% 31 Dec 2020 10-K 11 Feb 2022 2021 FY
Q3 2020 $1,842,659,000 30 Sep 2020 10-Q 30 Oct 2020 2020 Q3
Q2 2020 $1,456,653,000 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $1,161,112,000 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $997,787,000 31 Dec 2019 10-K 16 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.